Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one of the largest AI partnerships in the pharma industry to date. According to ...
Pharmaceutical Technology on MSN
Pharmaceutical Technology’s parent company GlobalData moves to main market of LSE
The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term strategy.
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...
Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...
BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...
Stephen Ranjan believes teamwork is just as crucial as technology in building successful digital healthcare solutions in the pharma space Stephen Ranjan learned how to be innovative while growing up ...
Pharmaceutical Technology on MSN
Europe’s pharma trade with the US remains critical despite tariff turmoil
New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.
Getting healthcare professionals to visit, spend time on and engage with a brand’s HCP website is essential to any pharma marketer’s digital strategy. Yet, the experience doctors encounter on these ...
Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving ...
Unlike Big Tech that rules the business world, and the world in general, as developed communities can hardly imagine their daily existence without its offerings, Big Pharma doesn’t get the same credit ...
Is the benefit to your medical group of maintaining ongoing relationships with pharma reps worth the cost? That’s a question confronting thousands of hospitals and medical groups today. Many factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results